Vaxart (VXRT) Announces Earnings Results

Vaxart (NASDAQ:VXRT) announced its quarterly earnings results on Friday. The biotechnology company reported ($0.92) EPS for the quarter, MarketWatch Earnings reports. The business had revenue of $0.28 million for the quarter. Vaxart had a negative net margin of 317.57% and a negative return on equity of 195.55%.

Shares of NASDAQ VXRT traded down $0.34 during trading on Friday, hitting $2.64. The stock had a trading volume of 183,719 shares, compared to its average volume of 99,802. Vaxart has a 12 month low of $2.37 and a 12 month high of $9.46. The company has a current ratio of 2.90, a quick ratio of 2.90 and a debt-to-equity ratio of 0.12.

ILLEGAL ACTIVITY NOTICE: “Vaxart (VXRT) Announces Earnings Results” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/11/10/vaxart-vxrt-announces-earnings-results.html.

About Vaxart

Vaxart, Inc, a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines.

Further Reading: S&P 500 Index

Earnings History for Vaxart (NASDAQ:VXRT)

Receive News & Ratings for Vaxart Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaxart and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply